Mesoblast Files Director Interest Notice
Ticker: MEOBF · Form: 6-K · Filed: Nov 18, 2024 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Nov 18, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-filing, director-interest
TL;DR
MESO filed a director interest notice on Nov 15. Check for insider moves.
AI Summary
On November 15, 2024, Mesoblast Limited filed a Final Director's Interest Notice (Appendix 3Z) with the Australian Securities Exchange. This filing is an update regarding director interests.
Why It Matters
This filing provides transparency into director holdings, which can be an indicator of insider confidence or changes in ownership structure.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of director interests and does not contain significant financial or operational news.
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- November 15, 2024 (date) — Filing date of Director's Interest Notice
- Appendix 3Z (document) — Type of Director's Interest Notice filed
FAQ
What type of filing did Mesoblast Limited submit on November 15, 2024?
Mesoblast Limited filed a Final Director's Interest Notice (Appendix 3Z).
Where was the Director's Interest Notice filed?
The notice was filed with the Australian Securities Exchange.
Who is the CEO and Executive Director of Mesoblast Limited?
Silviu Itescu is the Chief Executive Officer and Executive Director.
What is the principal executive office address for Mesoblast Limited?
The address is Level 38, 55 Collins Street, Melbourne 3000, Australia.
Does Mesoblast Limited file annual reports under Form 20-F or Form 40-F?
Mesoblast Limited files annual reports under Form 20-F.
Filing Stats: 300 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2024-11-18 06:47:55
Filing Documents
- a2024-11x182024agmappendix.htm (6-K) — 23KB
- exhibit991-appendix3zxjo.htm (EX-99.1) — 4KB
- exhibit992-chairsaddress.htm (EX-99.2) — 9KB
- exhibit993-agm2024presen.htm (EX-99.3) — 46KB
- exhibit994-resultsofmeet.htm (EX-99.4) — 6KB
- exhibit991-appendix3zxjo001.jpg (GRAPHIC) — 104KB
- exhibit991-appendix3zxjo002.jpg (GRAPHIC) — 92KB
- exhibit992-chairsaddress001.jpg (GRAPHIC) — 255KB
- exhibit992-chairsaddress002.jpg (GRAPHIC) — 300KB
- exhibit993-agm2024presen001.jpg (GRAPHIC) — 63KB
- exhibit993-agm2024presen002.jpg (GRAPHIC) — 155KB
- exhibit993-agm2024presen003.jpg (GRAPHIC) — 81KB
- exhibit993-agm2024presen004.jpg (GRAPHIC) — 106KB
- exhibit993-agm2024presen005.jpg (GRAPHIC) — 129KB
- exhibit993-agm2024presen006.jpg (GRAPHIC) — 101KB
- exhibit993-agm2024presen007.jpg (GRAPHIC) — 104KB
- exhibit993-agm2024presen008.jpg (GRAPHIC) — 146KB
- exhibit993-agm2024presen009.jpg (GRAPHIC) — 115KB
- exhibit993-agm2024presen010.jpg (GRAPHIC) — 118KB
- exhibit993-agm2024presen011.jpg (GRAPHIC) — 89KB
- exhibit993-agm2024presen012.jpg (GRAPHIC) — 65KB
- exhibit993-agm2024presen013.jpg (GRAPHIC) — 67KB
- exhibit993-agm2024presen014.jpg (GRAPHIC) — 93KB
- exhibit993-agm2024presen015.jpg (GRAPHIC) — 143KB
- exhibit993-agm2024presen016.jpg (GRAPHIC) — 104KB
- exhibit993-agm2024presen017.jpg (GRAPHIC) — 97KB
- exhibit993-agm2024presen018.jpg (GRAPHIC) — 130KB
- exhibit993-agm2024presen019.jpg (GRAPHIC) — 128KB
- exhibit993-agm2024presen020.jpg (GRAPHIC) — 93KB
- exhibit993-agm2024presen021.jpg (GRAPHIC) — 85KB
- exhibit993-agm2024presen022.jpg (GRAPHIC) — 135KB
- exhibit993-agm2024presen023.jpg (GRAPHIC) — 68KB
- exhibit993-agm2024presen024.jpg (GRAPHIC) — 51KB
- exhibit993-agm2024presen025.jpg (GRAPHIC) — 123KB
- exhibit993-agm2024presen026.jpg (GRAPHIC) — 106KB
- exhibit993-agm2024presen027.jpg (GRAPHIC) — 129KB
- exhibit993-agm2024presen028.jpg (GRAPHIC) — 107KB
- exhibit993-agm2024presen029.jpg (GRAPHIC) — 72KB
- exhibit993-agm2024presen030.jpg (GRAPHIC) — 63KB
- exhibit993-agm2024presen031.jpg (GRAPHIC) — 148KB
- exhibit993-agm2024presen032.jpg (GRAPHIC) — 148KB
- exhibit993-agm2024presen033.jpg (GRAPHIC) — 161KB
- exhibit993-agm2024presen034.jpg (GRAPHIC) — 118KB
- exhibit993-agm2024presen035.jpg (GRAPHIC) — 150KB
- exhibit993-agm2024presen036.jpg (GRAPHIC) — 134KB
- exhibit993-agm2024presen037.jpg (GRAPHIC) — 117KB
- exhibit993-agm2024presen038.jpg (GRAPHIC) — 37KB
- exhibit994-resultsofmeet001.jpg (GRAPHIC) — 55KB
- exhibit994-resultsofmeet002.jpg (GRAPHIC) — 160KB
- exhibit994-resultsofmeet003.jpg (GRAPHIC) — 122KB
- 0001345099-24-000079.txt ( ) — 7211KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Niva Sivakumar Niva Sivakumar Company Secretary Dated November 18, 2024 INDEX TO EXHIBITS Item 99.1 Final Director's Interest Notice, Joseph Swedish, dated November 15, 2024. 99.2 Chair's Annual General Meeting address , dated November 15, 2024. 99.3 CEO Presentation to Annual General Meeting , dated November 15, 2024. 99.4 Results of Annual General Meeting, dated November 15, 2024.